(CGAU) Centerra Gold - NYSE
Sector: Basic Materials | Industry: Gold | Exchange: NYSE (USA) | Market Cap: 3.295m USD | Total Return: 126.1% in 12m
Avg Turnover: 26.3M
Qual. Beats: 0
Rev. Trend: 85.4%
Qual. Beats: 1
Warnings
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
Centerra Gold Inc. (NYSE: CGAU) is a Canadian-based mining company incorporated in 2002 and headquartered in Toronto. It engages in the operation, development, exploration, and acquisition of gold and copper properties, with a geographic footprint spanning North America, Turkey, and other international regions. In addition to its precious metals portfolio, Centerra maintains a molybdenum business unit that includes a metallurgical processing facility and two primary molybdenum properties.
The companys principal assets include the Mount Milligan gold-copper mine in British Columbia, the Öksüt gold mine in Türkiye, the Kemess project in British Columbia, the Goldfield District project in Nevada, the Thompson Creek Mine in Idaho, and a 75% interest in the Endako Mine in British Columbia. Centerra is classified within the Materials sector under the Diversified Metals & Mining sub-industry, reflecting its multi-commodity exposure across gold, copper, and molybdenum.
Its diversified commodity mix is notable within the gold mining industry, where peers often focus exclusively on precious metals; the inclusion of copper and molybdenum operations provides exposure to industrial and base metals demand cycles alongside traditional gold production.
- Gold and copper prices drive Mount Milligan revenue
- Turkish permit risk weighs on Öksüt gold mine outlook
- Molybdenum segment provides cash flow diversification
| Net Income: 635.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.36 > 1.0 |
| NWC/Revenue: 42.98% < 20% (prev 57.34%; Δ -14.36% < -1%) |
| CFO/TA 0.13 > 3% & CFO 408.6m > Net Income 635.9m |
| Net Debt (-510.0m) to EBITDA (949.0m): -0.54 < 3 |
| Current Ratio: 2.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (201.5m) vs 12m ago -5.72% < -2% |
| Gross Margin: 34.93% > 18% (prev 31.70%; Δ 3.23% > 0.5%) |
| Asset Turnover: 57.26% > 50% (prev 52.31%; Δ 4.95% > 0%) |
| Interest Coverage Ratio: 51.90 > 6 (EBIT TTM 828.3m / Interest Expense TTM 16.0m) |
| A: 0.22 (Total Current Assets 1.14b - Total Current Liabilities 472.3m) / Total Assets 3.09b |
| B: 0.46 (Retained Earnings 1.43b / Total Assets 3.09b) |
| C: 0.31 (EBIT TTM 828.3m / Avg Total Assets 2.70b) |
| D: 2.14 (Book Value of Equity 2.10b / Total Liabilities 981.3m) |
| Altman-Z'' = 7.23 = AAA |
| DSRI: 0.67 (Receivables 134.7m/157.7m, Revenue 1.54b/1.21b) |
| GMI: 0.91 (GM 31.70% / 34.93%) |
| AQI: 1.31 (AQ_t 0.09 / AQ_t-1 0.07) |
| SGI: 1.28 (Revenue 1.54b / 1.21b) |
| TATA: 0.07 (NI 635.9m - CFO 408.6m) / TA 3.09b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of June 26, 2026, the stock is trading at USD 15.81 with a total of 1,151,714 shares traded. Over the past week, the price has changed by -9.19%, over one month by -9.24%, over three months by -6.38% and over the past year by +126.13%.
Current recommended Stop Loss: 14.30 (which is 9.6% or 1.7 ATR below the current price).
Centerra Gold has received a consensus analysts rating of 3.75. Therefore, it is recommended to hold CGAU.
- StrongBuy: 3
- Buy: 5
- Hold: 2
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 17.8 | 12.3% |
P/E Trailing = 5.3516
P/E Forward = 8.9047
P/S = 2.0989
P/B = 1.571
Revenue TTM = 1.54b USD
EBIT TTM = 828.3m USD
EBITDA TTM = 949.0m USD
Long Term Debt = 35.6m USD (estimated: total debt 43.9m - short term 8.23m)
Short Term Debt = 8.23m USD (from shortTermDebt, last quarter)
Debt = 43.9m USD (from shortLongTermDebtTotal, last quarter) (leases 43.7m already included)
Net Debt = -510.0m USD (calculated: Debt 43.9m - CCE 553.9m)
Enterprise Value = 2.78b USD (3.29b + Debt 43.9m - CCE 553.9m)
Interest Coverage Ratio = 51.90 (Ebit TTM 828.3m / Interest Expense TTM 16.0m)
EV/FCF = 21.11x (Enterprise Value 2.78b / FCF TTM 131.9m)
FCF Yield = 4.74% (FCF TTM 131.9m / Enterprise Value 2.78b)
FCF Margin = 8.54% (FCF TTM 131.9m / Revenue TTM 1.54b)
Net Margin = 41.17% (Net Income TTM 635.9m / Revenue TTM 1.54b)
Gross Margin = 34.93% ((Revenue TTM 1.54b - Cost of Revenue TTM 1.01b) / Revenue TTM)
Gross Margin QoQ = 40.77% (prev 31.35%)
Tobins Q-Ratio = 0.90 (Enterprise Value 2.78b / Total Assets 3.09b)
Interest Expense / Debt = 36.37% (Interest Expense 16.0m / Debt 43.9m)
Taxrate = 21.71% (176.4m / 812.3m)
NOPAT = 648.4m (EBIT 828.3m * (1 - 21.71%))
Current Ratio = 2.41 (Total Current Assets 1.14b / Total Current Liabilities 472.3m)
Debt / Equity = 0.02 (Debt 43.9m / totalStockholderEquity, last quarter 2.10b)
Debt / EBITDA = -0.54 (Net Debt -510.0m / EBITDA 949.0m)
Debt / FCF = -3.87 (Net Debt -510.0m / FCF TTM 131.9m)
Total Stockholder Equity = 1.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 23.58% (Net Income 635.9m / Total Assets 3.09b)
RoE = 32.60% (Net Income TTM 635.9m / Total Stockholder Equity 1.95b)
RoCE = 41.70% (EBIT 828.3m / Capital Employed (Equity 1.95b + L.T.Debt 35.6m))
RoIC = 25.49% (NOPAT 648.4m / Invested Capital 2.54b)
WACC = 9.72% (E(3.29b)/V(3.34b) * Re(9.47%) + D(43.9m)/V(3.34b) * Rd(36.37%) * (1-Tc(0.22)))
Discount Rate = 9.47% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -80.90 | Cagr: -2.94%
[DCF] Terminal Value 73.67% ; FCFF base≈106.1m ; Y1≈121.7m ; Y5≈179.1m
[DCF] Fair Price = 13.50 (EV 2.17b - Net Debt -510.0m = Equity 2.68b / Shares 198.6m; r=9.72% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.10 | # QB: 0
Revenue Correlation: 85.42 | Revenue CAGR: 17.27% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.50 | Chg30d=+7.87% | Revisions=-14% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.53 | Chg30d=N/A | Revisions=+14% | Analysts=6
EPS current Year (2026-12-31): EPS=1.88 | Chg30d=-2.60% | Revisions=-7% | GrowthEPS=+69.4% | GrowthRev=+23.1%
EPS next Year (2027-12-31): EPS=2.06 | Chg30d=-2.94% | Revisions=+0% | GrowthEPS=+9.4% | GrowthRev=+7.3%
[Analyst] Revisions Ratio: -14%